by Philip Morris | Nov 1, 2015 | Articles
Greater transparency for financial arrangements between pharmaceutical companies and doctors In early 2015 the Australian Consumer and Competition Commission (ACCC) authorized a new Code of Conduct for Medicines Australia (representing the larger drug companies... by Philip Morris | Apr 17, 2012 | Articles
Public Disclosure of Payments to Doctors from Drug Companies By Prof Philip Morris I note a newspaper report in The Australian on 18/2/12, recorded that, ‘GlaxoSmithKline’ drug company has stepped up it’s push for greater disclosure of industry payments to doctors,...